PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 70 filers reported holding PORTOLA PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,628,000 | +3.2% | 68,195 | +16.0% | 0.00% | 0.0% |
| Q3 2019 | $1,577,000 | +3.3% | 58,802 | +4.6% | 0.00% | 0.0% |
| Q2 2019 | $1,526,000 | -21.8% | 56,235 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $1,951,000 | +90.7% | 56,235 | +7.3% | 0.00% | +100.0% |
| Q4 2018 | $1,023,000 | -26.7% | 52,403 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $1,395,000 | -27.5% | 52,403 | +2.8% | 0.00% | -50.0% |
| Q2 2018 | $1,925,000 | -23.6% | 50,956 | -34.0% | 0.00% | -33.3% |
| Q1 2018 | $2,521,000 | -35.4% | 77,197 | -3.6% | 0.00% | -25.0% |
| Q4 2017 | $3,900,000 | -11.8% | 80,111 | -2.1% | 0.00% | -20.0% |
| Q3 2017 | $4,420,000 | +26.1% | 81,805 | +31.1% | 0.01% | 0.0% |
| Q2 2017 | $3,504,000 | +156.9% | 62,387 | +79.2% | 0.01% | +150.0% |
| Q1 2017 | $1,364,000 | +198.5% | 34,815 | +55.4% | 0.00% | +100.0% |
| Q1 2016 | $457,000 | -77.9% | 22,397 | -44.2% | 0.00% | -75.0% |
| Q4 2015 | $2,065,000 | +27.9% | 40,134 | +5.9% | 0.00% | +33.3% |
| Q3 2015 | $1,615,000 | -10.4% | 37,900 | -4.2% | 0.00% | -25.0% |
| Q2 2015 | $1,802,000 | +666.8% | 39,556 | +538.0% | 0.00% | +300.0% |
| Q1 2015 | $235,000 | -55.0% | 6,200 | -68.2% | 0.00% | -50.0% |
| Q3 2013 | $522,000 | – | 19,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 228,873 | $7,475,000 | 4.17% |
| PFM Health Sciences, LP | 5,326,671 | $173,969,000 | 3.54% |
| Marcus Capital, LLC | 22,950 | $750,000 | 2.76% |
| Partner Investment Management, L.P. | 72,284 | $2,361,000 | 2.55% |
| CADIAN CAPITAL MANAGEMENT, LP | 1,240,944 | $40,529,000 | 2.19% |
| HARVEY CAPITAL MANAGEMENT INC | 158,580 | $5,179,000 | 1.94% |
| SECTORAL ASSET MANAGEMENT INC | 498,412 | $16,278,000 | 1.78% |
| Everett Capital Advisors UK LLP | 551,173 | $18,001,000 | 1.52% |
| ROSENBLUM SILVERMAN SUTTON S F INC /CA | 125,210 | $4,089,000 | 1.46% |
| Atika Capital Management LLC | 113,000 | $3,691,000 | 1.26% |